Celebrating the 2-Year Anniversary of WellAI’s Machine Learning Tool
It’s hard to believe it’s been two years since we built our very first machine learning tool – WellAI’s COVID-19
Read moreIt’s hard to believe it’s been two years since we built our very first machine learning tool – WellAI’s COVID-19
Read moreIf you’ve been following us, you know how passionate we are about mathematical models and applications of data science in healthcare. You must then listen to this brand-new episode of Man & Machine hosted by a well-known family physician and AI enthusiast Dr. Ean Bett.
Read more2021 had its share of ups and downs. WellAI was no exception. But with every down, our team’s hard work
Read moreWe are excited to announce that Dr. Guy Culpepper, CEO of WellAI, will give a brief talk at Venture Summit 2021
Read moreDr. Guy Culpepper, CEO of WellAI, was voted by his peers as one of the best doctors in Dallas 29 years in a row!
Read moreWe are happy to tell you that WellAI won the “Most Innovative Use of AI” award at a recent Healthcare Analytics Summit (HAS’21).
Read moreCOVID research remains topical, 17 months after WellAI scientists invented a new analytical tool to fight COVID-19. At an annual IFCC conference, WellAI data scientists Sergei and Daniel talk about the “secret sauce” and describe the innovative ideas and research that went into the development of this tool. We are sharing this video for the first time.
Read moreSHERIDAN, Wyo., June 21, 2021 /PRNewswire/ — WellAI data scientists Daniel Satchkov and Sergei Polevikov will present their latest research “How AI Can Leverage
Read moreWe are thrilled to announce that WellAI data scientists Daniel and Sergei were invited to present our latest research “𝑯𝒐𝒘 𝑨𝑰 𝑪𝒂𝒏 𝑳𝒆𝒗𝒆𝒓𝒂𝒈𝒆 30 𝑴𝒊𝒍𝒍𝒊𝒐𝒏 𝑴𝒆𝒅𝒊𝒄𝒂𝒍 𝑺𝒕𝒖𝒅𝒊𝒆𝒔 𝒕𝒐 𝑰𝒎𝒑𝒓𝒐𝒗𝒆 𝑪𝒂𝒓𝒆” at Healthcare Analytics Summit (HAS) 2021, with coach 𝐒𝐭𝐞𝐯𝐞 𝐊𝐞𝐫𝐫 of NBA’s Golden State Warriors as the keynote speaker.
Read moreSHERIDAN, Wyo., Feb. 13, 2021 /PRNewswire/ — WellAI data scientists Sergei Polevikov and Daniel Satchkov are to present their COVID-19 research based on an
Read more